• Expert insights

    Professors Andrew Blauvelt, Ulrich Mrowietz, Paolo Gisondi and Rolland Gyulai address a number of questions in a video series, including:

    • What role will biosimilars play in the management of psoriasis?
    • How have the guidelines and treatment armamentarium changed recently?

  • Psoriasis Treatment

    Read about the established topical, systemic and biologic treatments available for psoriasis as well as novel treatments, such as TNFα and interleukin antagonists.

  • Pathophysiology

    A detailed overview of the mechanisms behind the initiation and maintenance of psoriasis.

 

Welcome to the Psoriasis Learning Zone

Psoriasis is a chronic inflammatory disease that often presents with disfiguring, scaling and erythematous plaques of the skin. The Psoriasis Learning Zone is an educational resource that offers a concise overview of the different forms of psoriasis, including plaque psoriasis and guttate psoriasis. The Psoriasis Learning Zone also covers epidemiology, underlying pathophysiology and classification of disease severity from mild to severe psoriasis, as measured by BSA, PASI or PGA.

The ‘treatment’ section features comprehensive information on the history, efficacy and safety of available psoriasis treatments, as well as up-to-date insights into the novel therapeutics currently in development.  

Want to know more about the changing treatment landscape in psoriasis? Take the interactive EACCME accredited CME to find out more on the burden of psoriasis, its common comorbidities and how the addition of novel treatment types is changing the possible outcomes for patients with moderate-to-severe psoriasis.

The Psoriasis Learning Zone was last updated in December 2019 and was reviewed for accuracy by Professor Rolland Gyulai, MD, PhD.

Treatment

Treatment

Read about the established topical, systemic and biologic treatments available for psoriasis as well as novel treatments including tumour necrosis factor-α (TNFα) and interleukin (IL) antagonists.

Guidelines

Guidelines

Read about, and access, the current guidelines for the management of psoriasis developed by the AAD, EADV, the British Association of Dermatologists and more.

Comorbidities

Comorbidities

This section provides an overview of some of the comorbidities associated with psoriasis, their impact on mortality and the implications for patient management.

Disease Awareness

Disease Awareness

Psoriasis is a chronic inflammatory disease. Learn about its pathophysiology, triggers, epidemiology and the impact it can have on patients.


Login/ Register Maximise Minimise